Montefiore Medical Center
The Bronx, New York, 10467, United States
NCT Number: NCT01011673
Occasionally, episodic tension-type headache may be severe enough to require an emergency department (ED) visit. The purpose of this study is to compare two commonly used medications to see which is better for tension type headache. Patients who present to the ED with an acute tension-type headache requiring treatment with injectable medication will be randomized to metoclopramide or ketorolac.
Looking for future studies?
Notify Me21 year–64 year
All sexes
Interventional
Phase 4
The Bronx, New York, 10467, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
metoclopramide 20mg IVSS + diphenhydramine 25mg IVSS
Other names: Reglan
ketorolac 30mg IVSS
Other names: Toradol
Time frame: Baseline, 60 minutes
At baseline at at 60 minutes, all patients were asked to describe their pain on a scale from 0 to 10, with 0 representing no pain and 10 the worst imaginable. The primary outcome is the 60 minute score subtracted from the baseline score
Time frame: 24 hours
24 hours after the emergency department visit, patients were asked, "The next time you come to the Er with this type of headache, do you want to receive the same medication?" Affirmative answers are tabulated here.
Montefiore Medical Center
Other
An RCT of Metoclopramide/Diphenhydramine vs. Ketorolac Alone for Tension-type Headache
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04736654
Brain Diseases, Central Nervous System Diseases
Ankara, None Selected, Turkey (Türkiye)
View Trial DetailsNCT04765501
Brain Diseases, Central Nervous System Diseases
Ankara, None Selected, Turkey (Türkiye)
View Trial DetailsNCT06155669
Agnosia, Analgesia
Ankara, Çankaya, Turkey (Türkiye)
View Trial DetailsNCT04950413
Brain Diseases, Central Nervous System Diseases
Dokki, Egypt
View Trial Details